Itinerant Itin leaves Micromet for refuelled Cytos
This article was originally published in Scrip
Executive Summary
Dr Christian Itin has left his position as president and CEO of Micromet, a company acquired by Amgen in January for £1.1 billion, to join Swiss company Cytos Biotechnology as CEO.